SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-18-066584
Filing Date
2018-12-28
Accepted
2018-12-28 16:31:57
Documents
2
Period of Report
2018-12-21

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv510064_form3.html 3  
1 OWNERSHIP DOCUMENT tv510064_form3.xml 3 5215
2 EXHIBIT 24 tv510064_ex24.htm EX-24 10168
  Complete submission text file 0001144204-18-066584.txt   17052
Mailing Address 5 WEST FORSYTH STREET SUITE 200 JACKSONVILLE FL 32202
Business Address 5 WEST FORSYTH STREET SUITE 200 JACKSONVILLE FL 32202 (904) 516-5436
Marker Therapeutics, Inc. (Issuer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5 WEST FORSYTH STREET SUITE 200 JACKSONVILLE FL 32202
Business Address
Leen Ann M. (Reporting) CIK: 0001763026 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37939 | Film No.: 181257727